Labs / Assays & in vitro testing
Mestag Therapeutics
Cambridge, United Kingdom · mestagtherapeutics.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Mestag Therapeutics is an immunology company developing antibody-based therapies for cancer and inflammatory diseases by targeting fibroblast biology. It is based at Chesterford Research Park in Little Chesterford, Cambridge, UK.
Their website has a general contact form; we send your quote request through it.
What they offer
Antibody therapy development
Develops agonist antibody programs for cancer and inflammatory diseases.
Bispecific antibody development
Advances MST-0312, a bispecific antibody designed to drive tertiary lymphoid structures in solid tumors.
Target discovery via RAFT platform
Explores the RAFT target discovery platform to identify new targets for treatment development.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Cell therapy
- Therapeutic areas
- cancer, inflammatory disease, RA, IBD, lupus, solid tumors
- Sites
- Little Chesterford, Cambridge, UK
- Address
- during 8 years at Merck KGaA (Geneva) in a series of Global Corporat
- Founded
- 2016
Similar labs. Sparx BIO, Aurigene Pharmaceutical Services, Evotec, Intellective Bio
Found in a contract services directory. Listing built from mestagtherapeutics.com. Work here? Claim this listing.